LS
USNA icon

Livforsakringsbolaget Skandia’s Usana Health Sciences USNA Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-4,000
Closed -$145K – 180
2013
Q2 		$145K Buy
+4,000
New +$122K 0.1% 150

Other funds holding USNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Livforsakringsbolaget Skandia's USNA Position: Q3 2013 in Review

Livforsakringsbolaget Skandia sold out of Usana Health Sciences (USNA) in Q3 2013, closing a stake of 4,000 shares — an estimated $145K sold.

Livforsakringsbolaget Skandia first reported a position in USNA in Q2 2013 and held it in 1 quarter. The position peaked at $145K in Q2 2013. 139 funds tracked by Wall St. Rank hold USNA as of Q3 2013.

  • Livforsakringsbolaget Skandia reported no remaining Usana Health Sciences position as of Q3 2013 after selling out during the quarter.
  • Livforsakringsbolaget Skandia sold 4,000 Usana Health Sciences shares in Q3 2013, an estimated $145K.
  • Livforsakringsbolaget Skandia first reported a position in Usana Health Sciences in Q2 2013 and held it in 1 quarter.
  • Livforsakringsbolaget Skandia's Usana Health Sciences position peaked at $145K in Q2 2013.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2013.

Based on Livforsakringsbolaget Skandia's 13F filing for Q3 2013, filed 16 Oct 2013.